今日も日本のニュースを英語で読んでいきましょう。
Using iPS cells to treat type 1 diabetes, Kyoto University Hospital Announces Commencement of Clinical Trials
Regarding type 1 diabetes, which is said to occur due to abnormalities in the immune system, Kyoto University Hospital has announced that they have started a clinical trial to make cells that secrete “insulin” that lowers blood sugar levels from iPS cells and transplant them into patients. The progress of the first patient is good, and they hope to put it into practical use in the 2030s.
“Type 1 diabetes” is a disease in which cells that secrete insulin that lower blood sugar levels do not work normally due to abnormalities in the immune system, and it is said that there are more than 120,000 patients in Japan.
Kyoto University Hospital held a press conference in Kyoto on the 14th and announced that they have started a clinical trial to create “islet cells” that secrete insulin from iPS cells of healthy people, make them into sheets, and transplant them into the abdomen of patients with type 1 diabetes.
The first surgery was performed in February, and a sheet of several centimeters square made by a venture company in Kanagawa Prefecture was transplanted onto a female patient in her 40s.
The purpose of this clinical trial was to confirm the progress of the clinical trial, focusing on safety, and the woman had already been discharged from the hospital, and there were no major safety problems by one month after surgery.
The research team plans to perform transplant surgery on two more people in the future, and wants to aim for practical use in the 2030s after confirming the effectiveness. Daisuke Yabe, a professor of diabetes, endocrinology, and nutrition at the Kyoto University Graduate School of Medicine, said, “There are no major problems, and we can say that we have succeeded enough at this stage.
Reference from: NHK WEB
今日は、due to〜をピックアップ。
翻訳すると、due to ~ ＝ 〜のために（〜の原因によって）
ビジネスで特によく使われる比較的フォーマルな表現です。
カジュアルな日常会話では、because of~ を代わりに使うことができます。
それではまた〜！
